In today’s episode, we will be talking with Debra Dow, COO of Symbio and Dow Development Laboratories (DDL). This episode focuses on how DDL got started, the many services offered today and a post-merger update.
With decades of experience, DDL has excelled and specialized in the design, development, and manufacture of topical drug products for a number of therapeutic indications. Their services include formulation development, product testing and methods, clinical supplies manufacture as well as clinical packaging & labeling. Also, FDA-registered and cGMP compliant, their custom-built facility occupies 23,000 square feet in Northern California,
Please enjoy this informative and interesting conversation between Rich Panico and Debra Dow!
